tiprankstipranks
Trending News
More News >
Annexon Biosciences (ANNX)
NASDAQ:ANNX
US Market

Annexon Biosciences (ANNX) Income Statement

Compare
1,311 Followers

Annexon Biosciences Income Statement

Last quarter (Q3 2025), Annexon Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Annexon Biosciences's net income was $-54.92M. See Annexon Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -3.45M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 150.62M$ 143.72M$ 145.60M$ 130.71M$ 63.47M
Depreciation and Amortization
$ 3.45M$ 2.15M$ 2.15M$ 2.14M$ 667.00K
EBITDA
$ -134.75M$ -141.57M$ -143.45M$ -128.57M$ -62.80M
Operating Income
$ -154.07M$ -143.72M$ -145.60M$ -130.71M$ -63.47M
Other Income/Expenses
$ 15.87M$ 9.49M$ 3.65M$ 390.00K$ 57.00K
Pretax Income
$ -138.20M$ -134.24M$ -141.95M$ -130.32M$ -63.41M
Net Income
$ -138.20M$ -134.24M$ -141.95M$ -130.32M$ -63.41M
Per Share Metrics
Basic EPS
$ -1.01$ -1.77$ -2.60$ -3.34$ -3.70
Diluted EPS
$ -1.01$ -1.77$ -2.60$ -3.34$ -3.70
Weighted Average Shares Outstanding
137.40M 75.67M 54.67M 38.32M 16.96M
Weighted Average Shares Outstanding (Diluted)
137.40M 75.67M 54.67M 38.32M 16.96M
Currency in USD

Annexon Biosciences Earnings and Revenue History